ALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-O-CRESOL
![]() |
- $29.8 - $503.73
- Product name: ALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-O-CRESOL
- CAS: 35717-67-0
- MF: C14H10F3NO
- MW: 265.23
- EINECS:
- MDL Number:MFCD00020073
- Synonyms:ALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-O-CRESOL;Phenol, 2-[[[2-(trifluoromethyl)phenyl]imino]methyl]-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 250mg
- 1 unit
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0304289
- Product descriptionALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-ORTHO-CRESOL 95.00%
- Packaging5MG
- Price$503.73
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS583952
- Product descriptionALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-O-CRESOL Aldrich
- Packaging250mg
- Price$29.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS583952
- Product descriptionALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-O-CRESOL AldrichCPR
- Packaging1 unit
- Price$30.7
- Updated2025-07-31
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0304289 | ALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-ORTHO-CRESOL 95.00% | 5MG | $503.73 | 2021-12-16 | Buy |
Sigma-Aldrich | S583952 | ALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-O-CRESOL Aldrich | 250mg | $29.8 | 2024-03-01 | Buy |
Sigma-Aldrich | S583952 | ALPHA-(2-(TRIFLUOROMETHYL)PHENYLIMINO)-O-CRESOL AldrichCPR | 1 unit | $30.7 | 2025-07-31 | Buy |
Properties
Boiling point :382.1±42.0 °C(Predicted)
Density :1.22±0.1 g/cm3(Predicted)
pka :8.31±0.30(Predicted)
Density :1.22±0.1 g/cm3(Predicted)
pka :8.31±0.30(Predicted)
Safety Information
Symbol(GHS): |
![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|